Skip to main content

What the FDA labels say about taking them together

Isocarboxazid and meperidine

Isocarboxazid's FDA label of April 21, 2026 names meperidine in its contraindications section; meperidine's label does not name isocarboxazid itself but warns about its class (MAO inhibitors).

Check it at the source: the isocarboxazid FDA label on DailyMed (effective April 21, 2026, Lifsa Drugs LLC); the meperidine FDA label on DailyMed (effective November 29, 2025, EPIC PHARMA, LLC).

What does the isocarboxazid label say about meperidine?

Isocarboxazid label, contraindications

Meperidine Meperidine should not be used concomitantly with MAO inhibitors or within 2- or 3-weeks following MAO therapy.

Source: FDA drug label (MARPLAN), Lifsa Drugs LLC, effective April 21, 2026 (SPL set 95fde749-44ad-4668-86c4-0ff17bca0074), via openFDA; the full label on DailyMed

What does the meperidine label say about isocarboxazid?

Meperidine's label does not name isocarboxazid itself; it warns about its class (MAO inhibitors):

Meperidine label, boxed warning

Concomitant use of Meperidine Hydrochloride Tablets with Monoamine Oxidase Inhibitors (MAOIs) Concomitant use of meperidine hydrochloride tablets with monoamine oxidase inhibitors (MAOIs) can result in coma, severe respiratory depression, cyanosis, and hypotension.

Meperidine label, boxed warning

Use of meperidine hydrochloride tablets with MAOIs within last 14 days is contraindicated [see Contraindications (4), Warnings and Precautions (5.8), Drug Interactions (7) ].

Source: FDA drug label (Meperidine Hydrochloride), EPIC PHARMA, LLC, effective November 29, 2025 (SPL set fae5cc34-5917-4445-9516-25f97ffca8db), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Isocarboxazid generic labelers
3Meperidine generic labelers
IsocarboxazidMeperidine
Labeled forDepressionPain
Boxed warningYesYes
Pharmacy cost (NADAC)n/a$0.157 per mL 50 mg/5 mL solution
Shortage nowIn shortageListed; available

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?